GSTM1 and COVID-19: In addition, it is acknowledged that COVID-19 patients present an increased risk of thrombosis [33]; therefore, patients with moderate to severe forms of COVID-19 and elevated Hb levels, as in our study, are associated with an increased risk of mortality, due to the exponential associated thrombotic risk.